Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in
Top

Cardiovascular Diabetology

Issue 1/2020

Content (213 Articles)

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)

Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa, Yosuke Okada, Takamasa Ichijo, Mariko Higa, Toru Hiyoshi, Ikuo Inoue, Kaoru Iso, Hidenori Yoshii, Takahisa Hirose, Naoki Kumashiro

Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study

Chi-Hung Liu, Tsong-Hai Lee, Yu-Sheng Lin, Pi-Shan Sung, Yi-Chia Wei, Yan-Rong Li

Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

William A. E. Parker, Christian Schulte, Temo Barwari, Fladia Phoenix, Sam M. Pearson, Manuel Mayr, Peter J. Grant, Robert F. Storey, Ramzi A. Ajjan

Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes

Chun-Pai Yang, Cheng-Chieh Lin, Chia-Ing Li, Chiu-Shong Liu, Chih-Hsueh Lin, Kai-Lin Hwang, Shing-Yu Yang, Tsai-Chung Li

Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?

Salva R. Yurista, Herman H. W. Silljé, Michiel Rienstra, Rudolf A. de Boer, B. Daan Westenbrink

Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure

Hidekazu Tanaka, Fumitaka Soga, Kazuhiro Tatsumi, Yasuhide Mochizuki, Hiroyuki Sano, Hiromi Toki, Kensuke Matsumoto, Junya Shite, Hideyuki Takaoka, Tomofumi Doi, Ken-ichi Hirata

Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy

M. Arow, M. Waldman, D. Yadin, V. Nudelman, A. Shainberg, N. G. Abraham, D. Freimark, R. Kornowski, D. Aravot, E. Hochhauser, M. Arad

Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients

Javad Alizargar, Chyi-Huey Bai, Nan-Chen Hsieh, Shu-Fang Vivienne Wu

Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study

Shilan Seyed Ahmadi, Ann-Marie Svensson, Aldina Pivodic, Annika Rosengren, Marcus Lind

Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis

Da-Peng Zhang, Li Xu, Le-Feng Wang, Hong-Jiang Wang, Feng Jiang

Association of insulin resistance, from mid-life to late-life, with aortic stiffness in late-life: the Atherosclerosis Risk in Communities Study

  • Open Access
  • Insulins
  • Original investigation

Anna K. Poon, Michelle L. Meyer, Hirofumi Tanaka, Elizabeth Selvin, James Pankow, Donglin Zeng, Laura Loehr, Joshua W. Knowles, Wayne Rosamond, Gerardo Heiss

Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes

Tianyuan Lu, Vincenzo Forgetta, Oriana H. Y. Yu, Lauren Mokry, Madeline Gregory, George Thanassoulis, Celia M. T. Greenwood, J. Brent Richards

Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction

Kim A. Connelly, Yanling Zhang, Jean-François Desjardins, Linda Nghiem, Aylin Visram, Sri N. Batchu, Verra G. Yerra, Golam Kabir, Kerri Thai, Andrew Advani, Richard E. Gilbert

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol

Helen M. Colhoun, Lawrence A. Leiter, Dirk Müller-Wieland, Bertrand Cariou, Kausik K. Ray, Francisco J. Tinahones, Catherine Domenger, Alexia Letierce, Marc Israel, Rita Samuel, Stefano Del Prato

Prognostic utility of heart-type fatty acid-binding protein in patients with stable coronary artery disease and impaired glucose metabolism: a cohort study

Hui-Wen Zhang, Jing-Lu Jin, Ye-Xuan Cao, Hui-Hui Liu, Yan Zhang, Yuan-Lin Guo, Na-Qiong Wu, Ying Gao, Rui-Xia Xu, Qi Hua, Yan-Fang Li, Chuan-Jue Cui, Geng Liu, Qian Dong, Jing Sun, Jian-Jun Li

Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes

Emilie H. Zobel, Regitse Højgaard Christensen, Signe A. Winther, Philip Hasbak, Christian Stevns Hansen, Bernt J. von Scholten, Lene Holmvang, Andreas Kjaer, Peter Rossing, Tine W. Hansen

Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients

Shih-Chieh Shao, Kai-Cheng Chang, Swu-Jane Lin, Rong-Nan Chien, Ming-Jui Hung, Yuk-Ying Chan, Yea-Huei Kao Yang, Edward Chia-Cheng Lai

Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study

  • Open Access
  • Original investigation

Takehiro Funamizu, Hiroshi Iwata, Yuya Nishida, Katsutoshi Miyosawa, Shinichiro Doi, Yuichi Chikata, Jun Shitara, Hirohisa Endo, Hideki Wada, Ryo Naito, Manabu Ogita, Tomotaka Dohi, Takatoshi Kasai, Shinya Okazaki, Kikuo Isoda, Katsumi Miyauchi, Hiroyuki Daida

Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat

Sin-Hee Park, Muhammad Akmal Farooq, Sébastien Gaertner, Christophe Bruckert, Abdul Wahid Qureshi, Hyun-Ho Lee, Djamel Benrahla, Brigitte Pollet, Dominique Stephan, Patrick Ohlmann, Jean-Marc Lessinger, Eric Mayoux, Cyril Auger, Olivier Morel, Valérie B. Schini-Kerth

Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes

Marco Witkowski, Mario Witkowski, Mona Saffarzadeh, Julian Friebel, Termeh Tabaraie, Loc Ta Bao, Aritra Chakraborty, Andrea Dörner, Bernd Stratmann, Diethelm Tschoepe, Samantha J. Winter, Andreas Krueger, Wolfram Ruf, Ulf Landmesser, Ursula Rauch

Mitochondrial 8-hydroxy-2′-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus

Xue-bin Wang, Ning-hua Cui, Xia’nan Liu, Xin Liu

The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China

Zheng Qin, Kuo Zhou, Yueping Li, Wanjun Cheng, Zhijian Wang, Jianlong Wang, Fei Gao, Lixia Yang, Yingkai Xu, Yafeng Wu, Hua He, Yujie Zhou

Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet

Vijayakumar Sukumaran, Hirotsugu Tsuchimochi, Takashi Sonobe, Mark T. Waddingham, Mikiyasu Shirai, James T. Pearson

The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety

Charles E. Leonard, Colleen M. Brensinger, Ghadeer K. Dawwas, Rajat Deo, Warren B. Bilker, Samantha E. Soprano, Neil Dhopeshwarkar, James H. Flory, Zachary T. Bloomgarden, Joshua J. Gagne, Christina L. Aquilante, Stephen E. Kimmel, Sean Hennessy

The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery

  • Open Access
  • Obesity
  • Original investigation

Svitlana Demyanets, Christoph Kaun, Alexandra Kaider, Walter Speidl, Manfred Prager, Stanislav Oravec, Philipp Hohensinner, Johann Wojta, Gersina Rega-Kaun

Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study

Lin Zhu, Andrew Hayen, Katy J. L. Bell

Empagliflozin improves cardiac function in heart failure with reduced ejection fraction independent of loading conditions

Bo Liang, Yu-Xiu Zhao, Ning Gu

Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation

Yi-Hsin Chan, Chi Chuang, Cze-Ci Chan, Hsin-Fu Lee, Ya-Chi Huang, Yu-Tung Huang, Shang-Hung Chang, Chun-Li Wang, Tze-Fan Chao, Chi-Tai Kuo, Yung-Hsin Yeh, Shih-Ann Chen

Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome

Xiaoteng Ma, Lisha Dong, Qiaoyu Shao, Yujing Cheng, Sai Lv, Yan Sun, Hua Shen, Zhijian Wang, Yujie Zhou, Xiaoli Liu

Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease—a comparison in the MONICA/KORA study

Cornelia Huth, Alina Bauer, Astrid Zierer, Julie Sudduth-Klinger, Christa Meisinger, Michael Roden, Annette Peters, Wolfgang Koenig, Christian Herder, Barbara Thorand

Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes

Ying Tang, Sheng-Lan Li, Jia-Hui Hu, Kai-Jun Sun, Lei-Ling Liu, Dan-Yan Xu

Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline

  • Open Access
  • Insulins
  • Original investigation

Ki-Bum Won, Eun Ji Park, Donghee Han, Ji Hyun Lee, Su-Yeon Choi, Eun Ju Chun, Sung Hak Park, Hae-Won Han, Jidong Sung, Hae Ok Jung, Hyuk-Jae Chang

Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney

Dario Giugliano, Luca De Nicola, Maria Ida Maiorino, Giuseppe Bellastella, Carlo Garofalo, Paolo Chiodini, Antonio Ceriello, Katherine Esposito

Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease

Shuo-Lin Liu, Na-Qiong Wu, Hui-Wei Shi, Qian Dong, Qiu-ting Dong, Ying Gao, Yuan-Lin Guo, Jian-Jun Li

Clinical outcomes after cardiac rehabilitation in elderly patients with and without diabetes mellitus: The EU-CaRE multicenter cohort study

Prisca Eser, Thimo Marcin, Eva Prescott, Leonie F. Prins, Evelien Kolkman, Wendy Bruins, Astrid E. van der Velde, Carlos Peña-Gil, Marie-Christine Iliou, Diego Ardissino, Uwe Zeymer, Esther P. Meindersma, Arnoud. W. J. Van’tHof, Ed P. de Kluiver, Markus Laimer, Matthias Wilhelm

Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline

María Teresa Julián, Núria Alonso, Josep Lupón, Giovana Gavidia-Bovadilla, Elena Ferrer, Marta de Antonio, Jorge López-Ayerbe, Mar Domingo, Evelyn Santiago-Vacas, Elisabet Zamora, Pau Codina, Pedro Moliner, Julio Núñez, Javier Santesmases, Manel Puig-Domingo, Antoni Bayes-Genis

Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus

  • Open Access
  • Diabetes
  • Original investigation

Zhenhua Xing, Zhenyu Peng, Xiaopu Wang, Zhaowei Zhu, Junyu Pei, Xinqun Hu, Xiangping Chai

The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes

Xingxing He, Jiaorong Su, Xiaojing Ma, Wei Lu, Wei Zhu, Yufei Wang, Yuqian Bao, Jian Zhou

Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study

Maryam Kabootari, Mitra Hasheminia, Fereidoun Azizi, Mohammadhassan Mirbolouk, Farzad Hadaegh

Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study

Ming-Yen Ng, Wenli Zhou, Varut Vardhanabhuti, Chi-Ho Lee, Esther Yee Tak Yu, Eric Yuk Fai Wan, Kit Chan, Andrew T. Yan, Tai-Pang Ip, Kai-Hang Yiu, Bernd J. Wintersperger

Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II

Jocelyn J. Drinkwater, Timothy M. E. Davis, Valentina Hellbusch, Angus W. Turner, David G. Bruce, Wendy A. Davis

The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study

Ji Hyun Lee, Kyungdo Han, Ji Hye Huh

Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study

Jing-Lu Jin, Hui-Wen Zhang, Ye-Xuan Cao, Hui-Hui Liu, Qi Hua, Yan-Fang Li, Yan Zhang, Na-Qiong Wu, Cheng-Gang Zhu, Rui-Xia Xu, Ying Gao, Xiao-Lin Li, Chuan-Jue Cui, Geng Liu, Jing Sun, Qian Dong, Yuan-Lin Guo, Jian-Jun Li

Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events

Valentina Spigoni, Federica Fantuzzi, Cecilia Carubbi, Giulia Pozzi, Elena Masselli, Giuliana Gobbi, Anna Solini, Riccardo C. Bonadonna, Alessandra Dei Cas

Report from the 5th cardiovascular outcome trial (CVOT) summit

Oliver Schnell, Eberhard Standl, Xavier Cos, Hiddo JL Heerspink, Baruch Itzhak, Nebojsa Lalic, Michael Nauck, Antonio Ceriello

Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial

  • Open Access
  • Insulins
  • Original investigation

Jie Zhang, Tong-Zhang Xian, Ming-Xiao Wu, Chen Li, Qi Pan, Li-Xin Guo

Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study

Min Gyu Kong, Se Yong Jang, Jieun Jang, Hyun-Jai Cho, Sangjun Lee, Sang Eun Lee, Kye Hun Kim, Byung-Su Yoo, Seok-Min Kang, Sang Hong Baek, Dong-Ju Choi, Eun-Seok Jeon, Jae-Joong Kim, Myeong-Chan Cho, Shung Chull Chae, Byung-Hee Oh, Soo Lim, Sue K. Park, Hae-Young Lee

Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study

Claudia R. L. Cardoso, Nathalie C. Leite, Gil F. Salles

Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study

Jun Hyung Kim, Jin Sil Moon, Seok Joon Byun, Jun Hyeok Lee, Dae Ryong Kang, Ki Chul Sung, Jang Young Kim, Ji Hye Huh

The additive effects of obesity on myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance first-pass perfusion study

  • Open Access
  • Obesity
  • Original investigation

Li Jiang, Ke Shi, Ying-kun Guo, Yan Ren, Zhen-lin Li, Chun-chao Xia, Lei Li, Xi Liu, Lin-jun Xie, Yue Gao, Meng-ting Shen, Ming-yan Deng, Zhi-gang Yang

High triglyceride-glucose index is associated with subclinical cerebral small vessel disease in a healthy population: a cross-sectional study

Ki-Woong Nam, Hyung-Min Kwon, Han-Yeong Jeong, Jin-Ho Park, Hyuktae Kwon, Su-Min Jeong

The relationship between carotid disease and retinopathy in diabetes: a systematic review

Jocelyn J. Drinkwater, Timothy M. E. Davis, Wendy A. Davis

Reappraisal on pharmacological and mechanical treatments of heart failure

Bo Liang, Yu-Xiu Zhao, Xiao-Xiao Zhang, Hui-Ling Liao, Ning Gu

Rho kinase cascade activation in circulating leukocytes in patients with diabetes mellitus type 2

  • Open Access
  • Metformin
  • Original investigation

Maria Paz Ocaranza, Patricio Valderas, Jackeline Moya, Luigi Gabrielli, Iván Godoy, Samuel Córdova, Paul Mac Nab, Lorena García, Luis Farías, Jorge E. Jalil

GLP-1 mediated diuresis and natriuresis are blunted in heart failure and restored by selective afferent renal denervation

  • Open Access
  • Neurotomy
  • Original investigation

Kenichi Katsurada, Shyam S. Nandi, Hong Zheng, Xuefei Liu, Neeru M. Sharma, Kaushik P. Patel

Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19

  • Open Access
  • Insulins
  • Original investigation

Huihui Ren, Yan Yang, Fen Wang, Yongli Yan, Xiaoli Shi, Kun Dong, Xuefeng Yu, Shujun Zhang

Impact of coronary collateralization on long-term clinical outcomes in type 2 diabetic patients after successful recanalization of chronic total occlusion

  • Open Access
  • Diabetes
  • Original investigation

Zhen Kun Yang, Ying Shen, Yang Dai, Xiao Qun Wang, Jian Hu, Feng Hua Ding, Rui Yan Zhang, Lin Lu, Wei Feng Shen

Trends in diabetes-related complications in Hong Kong, 2001–2016: a retrospective cohort study

Hongjiang Wu, Eric S. H. Lau, Aimin Yang, Ronald C. W. Ma, Alice P. S. Kong, Elaine Chow, Wing-Yee So, Juliana C. N. Chan, Andrea O. Y. Luk

Association of sleep disturbance with risk of cardiovascular disease and all-cause mortality in patients with new-onset type 2 diabetes: data from the Korean NHIS-HEALS

Young Choi, Jae Woo Choi

Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs

Milton Packer

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants

Yi-Hsin Chan, Hsin-Fu Lee, Pei-Ru Li, Jia-Rou Liu, Tze-Fan Chao, Lung-Sheng Wu, Shang-Hung Chang, Yung-Hsin Yeh, Chi-Tai Kuo, Lai-Chu See, Gregory Y. H. Lip

Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy

Shengwei Wang, Hao Cui, Keshan Ji, Changpeng Song, Changwei Ren, Hongchang Guo, Changsheng Zhu, Shuiyun Wang, Yongqiang Lai

Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials

Lisa Ludwig, Patrice Darmon, Bruno Guerci

Empagliflozin prevents doxorubicin-induced myocardial dysfunction

Jolanda Sabatino, Salvatore De Rosa, Laura Tammè, Claudio Iaconetti, Sabato Sorrentino, Alberto Polimeni, Chiara Mignogna, Andrea Amorosi, Carmen Spaccarotella, Masakazu Yasuda, Ciro Indolfi

Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study

Eonji Na, Sunyoung Cho, Dae Jung Kim, Junjeong Choi, Euna Han

Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status

Erika B. Parente, Valma Harjutsalo, Markku Lehto, Carol Forsblom, Niina Sandholm, Per-Henrik Groop

Different effects of SGLT2 inhibitors according to the presence and types of heart failure in type 2 diabetic patients

In-Chang Hwang, Goo-Yeong Cho, Yeonyee E. Yoon, Jin Joo Park, Jun-Bean Park, Seung-Pyo Lee, Hyung-Kwan Kim, Yong-Jin Kim, Dae-Won Sohn

Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: a 1H-magnetic resonance spectroscopy study

Yue Gao, Yan Ren, Ying-kun Guo, Xi Liu, Lin-jun Xie, Li Jiang, Meng-ting Shen, Ming-yan Deng, Zhi-gang Yang

Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome

Gong Su, Ming-Xi Gao, Gen-Ling Shi, Xi-Xi Dai, Wei-Feng Yao, Tao Zhang, Shao-Wei Zhuang

Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial

  • Open Access
  • Insulins
  • Original investigation

Hassan B. Awal, Seshagiri Rao Nandula, Cleyton C. Domingues, Fiona J. Dore, Nabanita Kundu, Beda Brichacek, Mona Fakhri, Adrian Elzarki, Neeki Ahmadi, Shauna Safai, Magan Fosso, Richard L. Amdur, Sabyasachi Sen

The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study

  • Open Access
  • Diabetes
  • Original investigation

Hung-Yi Chen, Jing-Yang Huang, Wun-Zhih Siao, Gwo-Ping Jong

Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice

Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, Gian Paolo Fadini

Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes

  • Open Access
  • Mannitol
  • Original investigation

Naoto Katakami, Kazuo Omori, Naohiro Taya, Shoya Arakawa, Mitsuyoshi Takahara, Taka-aki Matsuoka, Hiroshi Tsugawa, Masahiro Furuno, Takeshi Bamba, Eiichiro Fukusaki, Iichiro Shimomura

Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19

Celestino Sardu, Giuseppe Gargiulo, Giovanni Esposito, Giuseppe Paolisso, Raffaele Marfella

Hospitalization for heart failure incidence according to the transition in metabolic health and obesity status: a nationwide population-based study

You-Bin Lee, Da Hye Kim, Seon Mee Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Yong Gyu Park, Kyungdo Han, Hye Jin Yoo

High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study

  • Open Access
  • Obesity
  • Original investigation

Hyun-Jung Lee, Eue-Keun Choi, Kyung-Do Han, Da Hye Kim, Euijae Lee, So-Ryoung Lee, Seil Oh, Gregory Y. H. Lip

Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity

Cole D. Bendor, Aya Bardugo, Orit Pinhas-Hamiel, Arnon Afek, Gilad Twig

Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome

Le Wang, Hong-liang Cong, Jing-xia Zhang, Yue-cheng Hu, Ao Wei, Ying-yi Zhang, Hua Yang, Li-bin Ren, Wei Qi, Wen-yu Li, Rui Zhang, Jing-han Xu

Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study

Hyeok-Hee Lee, Yongin Cho, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Seok Won Park, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee, Kap Bum Huh

Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study

Bo Kyung Koo, Woo-Young Chung, Min Kyong Moon

Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort study

Chun-Ting Yang, Chen-Yi Yang, Huang-Tz Ou, Shihchen Kuo

Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy

Hidekazu Tanaka, Kazuhiro Tatsumi, Hiroki Matsuzoe, Kensuke Matsumoto, Ken-ichi Hirata

Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial

Atsushi Tanaka, Michio Shimabukuro, Yosuke Okada, Kazuhiro Sugimoto, Akira Kurozumi, Keiichi Torimoto, Hiroyuki Hirai, Koichi Node

Type 2 diabetes mellitus increases the mortality risk after acute coronary syndrome treated with coronary artery bypass surgery

Eilon Ram, Leonid Sternik, Robert Klempfner, Zaza Iakobishvili, Enrique Z. Fisman, Alexander Tenenbaum, Elchanan Zuroff, Yael Peled, Ehud Raanani

Generalizability of sodium-glucose co-transporter-2 inhibitors cardiovascular outcome trials to the type 2 diabetes population: a systematic review and meta-analysis

Marco Castellana, Filippo Procino, Rodolfo Sardone, Pierpaolo Trimboli, Gianluigi Giannelli

Associations of (pre)diabetes with right ventricular and atrial structure and function: the Maastricht Study

Pauline B. C. Linssen, Marja G. J. Veugen, Ronald M. A. Henry, Carla J. H. van der Kallen, Abraham A. Kroon, Miranda T. Schram, Hans-Peter Brunner-La Rocca, Coen D. A. Stehouwer

Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy

Masato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, Yukimura Higashiura, Akiko Sakai, Megumi Matsumoto, Mio Sakuma, Michio Shimabukuro, Takashi Nomiyama, Osamu Arasaki, Koichi Node, Shinichiro Ueda

Exercise-induced albuminuria increases over time in individuals with impaired glucose metabolism

Rafael Y. Brzezinski, Limor Friedensohn, Itzhak Shapira, David Zeltser, Ori Rogowski, Shlomo Berliner, Ayelet Grupper, Shani Shenhar-Tsarfaty

Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury

Charshawn Lahnwong, Siripong Palee, Nattayaporn Apaijai, Sirawit Sriwichaiin, Sasiwan Kerdphoo, Thidarat Jaiwongkam, Siriporn C. Chattipakorn, Nipon Chattipakorn

Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes

Magdalena Kopytek, Michał Ząbczyk, Piotr Mazur, Anetta Undas, Joanna Natorska

Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)

Manjunath Krishnappa, Kishor Patil, Krupi Parmar, Purav Trivedi, Nirali Mody, Chintan Shah, Khushboo Faldu, Sanjay Maroo, Piyush Desai, Kamlesh Fatania, Satyanarayan Murthy, R. Balamurugan, Manish Agarwal, K. P. Singh, G. S. Kalra, Vipul Khandelwal, Ashish Singwala, Hemant Thacker, Rahul Tulle, Harish Rao, Mukund Kumbla, Parminder Singh, Ashok Khatri, Sumit Agrawal, R. N. Sarkar, Dinesh Agarwal, Girish Bhatia, R. P. Agarwal, Surender Kumar, P. R. Vamsi Krishna, Ajay Kumar Ajmani, Amit Asalkar, Indraneel Basu, Sudip Chatterjee, Vinod Kumar Pavithran, Rupam Das, Aniruddha Dharmadhikari, Vikram Vardhan, M. Madusudhan Babu, Nilanjan Sengupta, Srirang Abkari, R. Harikrishna, Rashmi Chovatia, Deven Parmar

Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study

Yi-Chih Hung, Lu-Ting Chiu, Hung-Yu Huang, Da-Tian Bau

Comparison of heart failure risk and medical costs between patients with type 2 diabetes mellitus treated with dapagliflozin and dipeptidyl peptidase-4 inhibitors: a nationwide population-based cohort study

Jong-Mi Seong, Jong Joo Kim, Hae Jin Kim, Hyun Soon Sohn

Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis

Osamah M. Alfayez, Omar A. Almohammed, Omar S. Alkhezi, Abdulaali R. Almutairi, Majed S. Al Yami

Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort

Jung-Joon Cha, Hyoeun Kim, Young-Guk Ko, Donghoon Choi, Jae-Hwan Lee, Chang-Hwan Yoon, In-Ho Chae, Cheol Woong Yu, Seung Whan Lee, Sang-Rok Lee, Seung Hyuk Choi, Yoon Seok Koh, Pil-Ki Min, Woong Chol Kang, Sung-Ho Her, Yoon Seok Koh, Byung-Hee Hwang, Byung-Hee Hwang, Ae-Young Her, Weon Kim, Cheol Woong Yu, Sang Cheol Jo, Sang Cheol Jo, Sanghoon Shin, Yun Hyeong Cho, Woo-Young Chung, In-Ho Chae, Chang-Hwan Yoon, Jung Kyu Han, Seung Whan Lee, Seung Hyuk Choi, Young Jin Choi, Su Hyun Kim, Sang Ho Park, Pil-Ki Min, Donghoon Choi, Young-Guk Ko, Young Jin Yoon, Jung-Hee Lee, Yu Jeong Choi, Sung Kee Ryu, Ju Han Kim, Sang-Rok Lee, Hoyoun Won, Ju Yeol Baek, Jae-Hwan Lee, Jang-Hwan Bae, Hyun-Sook Kim

SGLT2i: beyond the glucose-lowering effect

Lihua Ni, Cheng Yuan, Guopeng Chen, Changjiang Zhang, Xiaoyan Wu

Cardiovascular and diabetes burden attributable to physical inactivity in Mexico

Catalina Medina, Pamela Coxson, Joanne Penko, Ian Janssen, Sergio Bautista-Arredondo, Simón Barquera, Kirsten Bibbins-Domingo

Long-term outcomes of medical therapy versus successful recanalisation for coronary chronic total occlusions in patients with and without type 2 diabetes mellitus

Lei Guo, Junjie Wang, Huaiyu Ding, Shaoke Meng, Xiaoyan Zhang, Haichen Lv, Lei Zhong, Jian Wu, Jiaying Xu, Xuchen Zhou, Rongchong Huang

Augmented glycaemic gap is a marker for an increased risk of post-infarct left ventricular systolic dysfunction

Yong Zhu, Kesen Liu, Shuai Meng, Ruofei Jia, Xuan Lei, Maolin Chen, Kaiyuan Zou, Huagang Zhu, Zening Jin

Glycemic variability: adverse clinical outcomes and how to improve it?

Zheng Zhou, Bao Sun, Shiqiong Huang, Chunsheng Zhu, Meng Bian

Prior bariatric surgery and perioperative cardiovascular outcomes following noncardiac surgery in patients with type 2 diabetes mellitus: hint from National Inpatient Sample Database

  • Open Access
  • Obesity
  • Original investigation

Jiewen Jin, Zhantao Deng, Lijuan Xu, Hai Li, Pengyuan Zhang, Liehua Liu, Juan Liu, Hedong Han, Zhimin Huang, Xiaopei Cao, Haipeng Xiao, Yanbing Li

The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes

  • Open Access
  • Diabetes
  • Original investigation

Ye-Xuan Cao, Hui-Wen Zhang, Jing-Lu Jin, Hui-Hui Liu, Yan Zhang, Ying Gao, Yuan-Lin Guo, Na-Qiong Wu, Qi Hua, Yan-Fang Li, Xiao-Lin Li, Rui-Xia Xu, Chuan-Jue Cui, Geng Liu, Qian Dong, Jing Sun, Cheng-Gang Zhu, Jian-Jun Li

Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes

Chen-Yi Yang, Pei-Fang Su, Jo-Ying Hung, Huang-Tz Ou, Shihchen Kuo

Liraglutide in the treatment of heart failure: insight from FIGHT and LIVE

Bo Liang, Ning Gu

Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study

David Thein, Mia Nielsen Christiansen, Ulrik Madvig Mogensen, Johan Skov Bundgaard, Rasmus Rørth, Christian Madelaire, Emil Loldrup Fosbøl, Morten Schou, Christian Torp-Pedersen, Gunnar Gislason, Lars Køber, Søren Lund Kristensen

Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China

Qi Zhao, Ting-Yu Zhang, Yu-Jing Cheng, Yue Ma, Ying-Kai Xu, Jia-Qi Yang, Yu-Jie Zhou

The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction

Jinxin Liu, Shanjie Wang, Can Cui, Hengxuan Cai, Rong Sun, Weili Pan, Shaohong Fang, Bo Yu

Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study

Naoto Katakami, Tomoya Mita, Hidenori Yoshii, Toshihiko Shiraiwa, Tetsuyuki Yasuda, Yosuke Okada, Keiichi Torimoto, Yutaka Umayahara, Hideaki Kaneto, Takeshi Osonoi, Tsunehiko Yamamoto, Nobuichi Kuribayashi, Kazuhisa Maeda, Hiroki Yokoyama, Keisuke Kosugi, Kentaro Ohtoshi, Isao Hayashi, Satoru Sumitani, Mamiko Tsugawa, Kayoko Ryomoto, Hideki Taki, Tadashi Nakamura, Satoshi Kawashima, Yasunori Sato, Hirotaka Watada, Iichiro Shimomura

Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study

Yan Zhang, Jing-Lu Jin, Ye-Xuan Cao, Hui-Wen Zhang, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Ying Gao, Qi Hua, Yan-Fang Li, Rui-Xia Xu, Jian-Jun Li

A high triglyceride glucose index is more closely associated with hypertension than lipid or glycemic parameters in elderly individuals: a cross-sectional survey from the Reaction Study

Binruo Zhu, Jie Wang, Kang Chen, Wenhua Yan, Anping Wang, Weiqing Wang, Zhengnan Gao, Xulei Tang, Li Yan, Qin Wan, Zuojie Luo, Guijun Qin, Lulu Chen, Yiming Mu

Quantitative assessment of coronary plaque volume change related to triglyceride glucose index: The Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry

Ki-Bum Won, Byoung Kwon Lee, Hyung-Bok Park, Ran Heo, Sang-Eun Lee, Asim Rizvi, Fay Y. Lin, Amit Kumar, Martin Hadamitzky, Yong-Jin Kim, Ji Min Sung, Edoardo Conte, Daniele Andreini, Gianluca Pontone, Matthew J. Budoff, Ilan Gottlieb, Eun Ju Chun, Filippo Cademartiri, Erica Maffei, Hugo Marques, Pedro de Araújo Gonçalves, Jonathon A. Leipsic, Sanghoon Shin, Jung Hyun Choi, Renu Virmani, Habib Samady, Kavitha Chinnaiyan, Gilbert L. Raff, Peter H. Stone, Daniel S. Berman, Jagat Narula, Leslee J. Shaw, Jeroen J. Bax, James K. Min, Hyuk-Jae Chang

Issues for the management of people with diabetes and COVID-19 in ICU

Antonio Ceriello, Eberhard Standl, Doina Catrinoiu, Baruch Itzhak, Nebojsa M. Lalic, Dario Rahelic, Oliver Schnell, Jan Škrha, Paul Valensi

Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies

Miriam Longo, Paola Caruso, Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano, Katherine Esposito

Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China

Chengping Hu, Jianwei Zhang, Jinxing Liu, Yan Liu, Ang Gao, Yong Zhu, Yingxin Zhao

The adipokine fatty-acid binding protein 4 and cardiac remodeling

Beatrice von Jeinsen, Lisa Ritzen, Julia Vietheer, Claudia Unbehaun, Maren Weferling, Christoph Liebetrau, Christian W. Hamm, Andreas Rolf, Till Keller

Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference

  • Open Access
  • Obesity
  • Original investigation

Heng Wan, Yuying Wang, Qian Xiang, Sijie Fang, Yi Chen, Chi Chen, Wen Zhang, Haojie Zhang, Fangzhen Xia, Ningjian Wang, Yingli Lu

Long term clinical impact of successful recanalization of chronic total occlusion in patients with and without type 2 diabetes mellitus

  • Open Access
  • Diabetes
  • Original investigation

Chuan-Tsai Tsai, Wei-Chieh Huang, Hsin-I Teng, Yi-Lin Tsai, Tse-Min Lu

Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease

Man Li, Lei Duan, Yu-Lun Cai, Hui-Ying Li, Ben-Chuan Hao, Jian-Qiao Chen, Hong-Bin Liu

Predictive values of ANGPTL8 on risk of all-cause mortality in diabetic patients: results from the REACTION Study

  • Open Access
  • Original investigation

Huajie Zou, Yongping Xu, Xi Chen, Ping Yin, Danpei Li, Wenjun Li, Junhui Xie, Shiying Shao, Liegang Liu, Xuefeng Yu

Patients with type 2 diabetes present with multiple anomalies of the pancreatic arterial tree on abdominal computed tomography: comparison between patients with type 2 diabetes and a matched control group

Laure Alexandre-Heymann, Matthias Barral, Anthony Dohan, Etienne Larger

Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance

  • Open Access
  • Insulins
  • Original investigation

Angela Sciacqua, Ettore Ventura, Giovanni Tripepi, Velia Cassano, Graziella D’Arrigo, Stefanos Roumeliotis, Raffale Maio, Sofia Miceli, Maria Perticone, Francesco Andreozzi, Giorgio Sesti, Francesco Perticone

Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis

Amera Halabi, Jonathan Sen, Quan Huynh, Thomas H. Marwick

Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke

Wen-Jun Tu, Han-Cheng Qiu, Ya-Kun Liu, Qiang Liu, Xianwei Zeng, Jizong Zhao

Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles

  • Open Access
  • Diabetes
  • Original investigation

Antonio J. Amor, Esmeralda Castelblanco, Marta Hernández, Marga Gimenez, Minerva Granado-Casas, Jesús Blanco, Berta Soldevila, Enric Esmatjes, Ignacio Conget, Nuria Alonso, Emilio Ortega, Didac Mauricio

Omega-3 polyunsaturated fatty acid supplementation versus placebo on vascular health, glycaemic control, and metabolic parameters in people with type 1 diabetes: a randomised controlled preliminary trial

Lauren L. O’Mahoney, Gareth Dunseath, Rachel Churm, Mel Holmes, Christine Boesch, Antonios Stavropoulos-Kalinoglou, Ramzi A. Ajjan, Karen M. Birch, Nicolas M. Orsi, Georgia Mappa, Oliver J. Price, Matthew D. Campbell

Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis

Xing Wang, Yu Zhang, Huiwen Tan, Peng Wang, Xi Zha, Weelic Chong, Liangxue Zhou, Fang Fang

Pericardial fat and its influence on cardiac diastolic function

  • Open Access
  • Original investigation

Vera H. W. de Wit-Verheggen, Sibel Altintas, Romy J. M. Spee, Casper Mihl, Sander M. J. van Kuijk, Joachim E. Wildberger, Vera B. Schrauwen-Hinderling, Bas L. J. H. Kietselaer, Tineke van de Weijer

SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials

Wen-jie Li, Xing-qing Chen, Ling-ling Xu, Yuan-qing Li, Bi-hui Luo

Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI

Chen Die Yang, Ying Shen, Feng Hua Ding, Zhen Kun Yang, Jian Hu, Wei Feng Shen, Rui Yan Zhang, Lin Lu, Xiao Qun Wang

Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care

Atsushi Tanaka, Koichi Node

Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention

Chen Die Yang, Ying Shen, Lin Lu, Zhen Kun Yang, Jian Hu, Rui Yan Zhang, Wei Feng Shen, Feng Hua Ding, Xiao Qun Wang

Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach

Lorenzo Nesti, Nicola Riccardo Pugliese, Paolo Sciuto, Andrea Natali

Macrophage accumulation within coronary arterial wall in diabetic patients with acute coronary syndrome: a study with in-vivo intravascular imaging modalities

Takaaki Kogo, Takafumi Hiro, Daisuke Kitano, Tadateru Takayama, Daisuke Fukamachi, Tomoyuki Morikawa, Mitsumasa Sudo, Yasuo Okumura

MicroRNAs and obesity-induced endothelial dysfunction: key paradigms in molecular therapy

Karima Ait-Aissa, Quynh My Nguyen, Mohanad Gabani, Adam Kassan, Santosh Kumar, Soo-Kyoung Choi, Alexis A. Gonzalez, Tahsin Khataei, Amal M. Sahyoun, Cheng Chen, Modar Kassan

Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes

  • Open Access
  • Insulins
  • Original investigation

Pham Viet Thai, Hoang Anh Tien, Huynh Van Minh, Paul Valensi

Long-term trajectories of BMI predict carotid stiffness and plaque volume in type 2 diabetes older adults: a cohort study

  • Open Access
  • Obesity
  • Original investigation

Chen Botvin Moshe, Salo Haratz, Ramit Ravona-Springer, Anthony Heymann, Lin Hung-Mo, Michal Schnaider Beeri, David Tanne

Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients: the China H-type Hypertension Registry Study

Minghui Li, Aihua Zhan, Xiao Huang, Lihua Hu, Wei Zhou, Tao Wang, Lingjuan Zhu, Huihui Bao, Xiaoshu Cheng

Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study

Olivier Bourron, Franck Phan, Mamadou Hassimiou Diallo, David Hajage, Carole-Elodie Aubert, Aurélie Carlier, Joe-Elie Salem, Christian Funck-Brentano, Salim Kemel, Philippe Cluzel, Alban Redheuil, Jean-Michel Davaine, Ziad Massy, Romuald Mentaverri, Dominique Bonnefont-Rousselot, Philippe Gillery, Stéphane Jaisson, Cees Vermeer, Jean-Marc Lacorte, Nesrine Bouziri, Suzanne Laroche, Chloé Amouyal, Agnes Hartemann

Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?

Coert J. Zuurbier

Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction

Takahiro Abe, Takashi Yokota, Arata Fukushima, Naoya Kakutani, Takashi Katayama, Ryosuke Shirakawa, Satoshi Maekawa, Hideo Nambu, Yoshikuni Obata, Katsuma Yamanashi, Ippei Nakano, Shingo Takada, Isao Yokota, Koichi Okita, Shintaro Kinugawa, Toshihisa Anzai

Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study

Jeong Mi Kim, Sang Soo Kim, In Joo Kim, Jong Ho Kim, Bo Hyun Kim, Mi Kyung Kim, Soon Hee Lee, Chang Won Lee, Min Chul Kim, Jun Hyeob Ahn, Jinmi Kim

Glucose variability and the risks of stroke, myocardial infarction, and all-cause mortality in individuals with diabetes: retrospective cohort study

Da Young Lee, Kyungdo Han, Sanghyun Park, Ji Hee Yu, Ji A. Seo, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Yong Gyu Park, Nan Hee Kim

Association of glucose uptake of visceral fat and acute myocardial infarction: a pilot 18F-FDG PET/CT study

Kisoo Pahk, Eung Ju Kim, Chanmin Joung, Hong Seog Seo, Sungeun Kim

Impact of long-term glucose variability on coronary atherosclerosis progression in patients with type 2 diabetes: a 2.3 year follow-up study

Suhua Li, Xixiang Tang, Yanting Luo, Bingyuan Wu, Zhuoshan Huang, Zexiong Li, Long Peng, Yesheng Ling, Jieming Zhu, Junlin Zhong, Jinlai Liu, Yanming Chen

Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study

Federico Biscetti, Elisabetta Nardella, Maria Margherita Rando, Andrea Leonardo Cecchini, Nicola Bonadia, Piergiorgio Bruno, Flavia Angelini, Carmine Di Stasi, Andrea Contegiacomo, Angelo Santoliquido, Dario Pitocco, Raffaele Landolfi, Andrea Flex

Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial

Wataru Shimizu, Yoshiaki Kubota, Yu Hoshika, Kosuke Mozawa, Shuhei Tara, Yukichi Tokita, Kenji Yodogawa, Yu-ki Iwasaki, Takeshi Yamamoto, Hitoshi Takano, Yayoi Tsukada, Kuniya Asai, Masaaki Miyamoto, Yasushi Miyauchi, Eitaro Kodani, Masahiro Ishikawa, Mitsunori Maruyama, Michio Ogano, Jun Tanabe, Reiko Shiomura, Isamu Fukuizumi, Junya Matsuda, Satsuki Noma, Hideto Sangen, Hidenori Komiyama, Yoichi Imori, Shunichi Nakamura, Jun Nakata, Hideki Miyachi, Gen Takagi, Takahiro Todoroki, Takeshi Ikeda, Tomoyo Miyakuni, Ayaka Shima, Masato Matsushita, Hirotake Okazaki, Akihiro Shirakabe, Nobuaki Kobayashi, Masamitsu Takano, Yoshihiko Seino, Yugo Nishi, Keishi Suzuki, Junsuke Shibuya, Tsunenori Saito, Hiroyuki Nakano, Morisawa Taichirou, Erito Furuse, Kenji Nakama, Yusuke Hosokawa, Ippei Tsuboi, Hidekazu Kawanaka

Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt-sensitive rats fed a high-salt and high-fat diet

  • Open Access
  • Original investigation

Masatoki Yoshida, Kazufumi Nakamura, Toru Miyoshi, Masashi Yoshida, Megumi Kondo, Kaoru Akazawa, Tomonari Kimura, Hiroaki Ohtsuka, Yuko Ohno, Daiji Miura, Hiroshi Ito

Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial

  • Open Access
  • Insulins
  • Original investigation

Christian Stevns Hansen, Louise Lundby-Christiansen, Lise Tarnow, Christian Gluud, Christoffer Hedetoft, Birger Thorsteinsson, Bianca Hemmingsen, Niels Wiinberg, Simone B. Sneppen, Søren S. Lund, Thure Krarup, Sten Madsbad, Thomas Almdal, Bendix Carstensen, Marit E. Jørgensen, T. Almdal, T. W. Boesgaard, L. Breum, B. Gade-Rasmussen, E. Duun, C. Gluud, C. Hedetoft, B. Hemmingsen, T. Jensen, T. Krarup, L. Lundby-Christensen, S. Lund, S. Madsbad, E. R. Mathiesen, O. Pedersen, H. Perrild, M. Røder, S. B. Sneppen, O. Snorgaard, L. Tarnow, B. Thorsteinsson, H. Vestergaard, A. Vaag, N. Wiinberg

Diabetes as a risk factor for incident peripheral arterial disease in women compared to men: a systematic review and meta-analysis

Alyssa Z. Chase-Vilchez, Isaac H. Y. Chan, Sanne A. E. Peters, Mark Woodward

Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes

Jing-Lu Jin, Hui-Wen Zhang, Ye-Xuan Cao, Hui-Hui Liu, Qi Hua, Yan-Fang Li, Yan Zhang, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Rui-Xia Xu, Ying Gao, Xiao-Lin Li, Chuan-Jue Cui, Geng Liu, Jing Sun, Qian Dong, Raul Santos, Jian-Jun Li

Exposure-weighted scoring for metabolic syndrome and the risk of myocardial infarction and stroke: a nationwide population-based study

Eun Young Lee, Kyungdo Han, Da Hye Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Mee Kyoung Kim, Seung-Hwan Lee

Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis

Elvira D’Andrea, Aaron S. Kesselheim, Jessica M. Franklin, Emily H. Jung, Spencer Phillips Hey, Elisabetta Patorno

The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study

Niloofar Barzegar, Maryam Tohidi, Mitra Hasheminia, Fereidoun Azizi, Farzad Hadaegh

Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials

Mansoor Husain, Stephen C. Bain, Anders Gaarsdal Holst, Thomas Mark, Søren Rasmussen, Ildiko Lingvay

Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes

Nam Ju Heo, Sang Youl Rhee, Jill Waalen, Steven Steinhubl

Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics

Martin H. Sørensen, Annemie S. Bojer, Niklas R. Jørgensen, David A. Broadbent, Sven Plein, Per L. Madsen, Peter Gæde

Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure

Alex Ali Sayour, Attila Oláh, Mihály Ruppert, Bálint András Barta, Eszter Mária Horváth, Kálmán Benke, Miklós Pólos, István Hartyánszky, Béla Merkely, Tamás Radovits

Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor

Hsin-Fu Lee, Shao-Wei Chen, Jia-Rou Liu, Pei-Ru Li, Lung-Sheng Wu, Shang-Hung Chang, Yung-Hsin Yeh, Chi-Tai Kuo, Yi-Hsin Chan, Lai-Chu See

The additive effects of type 2 diabetes mellitus on left ventricular deformation and myocardial perfusion in essential hypertension: a 3.0 T cardiac magnetic resonance study

Xue-Ming Li, Li Jiang, Ying-Kun Guo, Yan Ren, Pei-Lun Han, Li-Qing Peng, Rui Shi, Wei-Feng Yan, Zhi-Gang Yang

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes

Ryota Kakizaki, Yoshiyasu Minami, Masahiro Katamine, Aritomo Katsura, Yusuke Muramatsu, Takuya Hashimoto, Kentaro Meguro, Takao Shimohama, Junya Ako

Left atrial strain and diastolic function abnormalities in obese and type 2 diabetic adolescents and young adults

  • Open Access
  • Obesity
  • Original investigation

Jeremy M. Steele, Elaine M. Urbina, Wojciech M. Mazur, Philip R. Khoury, Sherif F. Nagueh, Justin T. Tretter, Tarek Alsaied

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)

Ernesto Maddaloni, Luca D’Onofrio, Francesco Alessandri, Carmen Mignogna, Gaetano Leto, Giuseppe Pascarella, Ivano Mezzaroma, Miriam Lichtner, Paolo Pozzilli, Felice Eugenio Agrò, Monica Rocco, Francesco Pugliese, Andrea Lenzi, Rury R. Holman, Claudio Maria Mastroianni, Raffaella Buzzetti, Camilla Ajassa, Rugova Alban, Francesco Alessandri, Federica Alessi, Raissa Aronica, Valeria Belvisi, Raffaella Buzzetti, Matteo Candy, Alessandra Caputi, Anna Carrara, Elena Casali, Eugenio Nelson Cavallari, Giancarlo Ceccarelli, Luigi Celani, Maria Rosa Ciardi, Lucia Coraggio, Ambrogio Curtolo, Claudia D’Agostino, Gabriella D’Ettorre, Luca D’Onofrio, Francesca De Giorgi, Gabriella De Girolamo, Valeria Filippi, Lucio Gnessi, Cecilia Luordi, Ernesto Maddaloni, Claudio Maria Mastroianni, Ivano Mezzaroma, Carmen Mignogna, Chiara Moretti, Francesco Pugliese, Gregorio Recchia, Marco Ridolfi, Francesco Eugenio Romani, Gianluca Russo, Franco Ruberto, Giulia Savelloni, Guido Siccardi, Antonio Siena, Sara Sterpetti, Serena Valeri, Mauro Vera, Lorenzo Volpicelli, Mikiko Watanabe, Massimo Aiuti, Giuseppe Campagna, Cosmo Del Borgo, Laura Fondaco, Blerta Kertusha, Frida Leonetti, Gaetano Leto, Miriam Lichtner, Raffaella Marocco, Renato Masala, Paola Zuccalà, Felice Eugenio Agrò, Giulia Nonnis, Giuseppe Pascarella, Paolo Pozzilli, Alessandra Rigoli, Alessandro Strumia, Daniela Alampi, Monica Rocco

Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS

T. M. Hommels, R. S. Hermanides, B. Berta, E. Fabris, G. De Luca, E. H. Ploumen, C. von Birgelen, E. Kedhi

Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine

Nicola Tecce, Maria Masulli, Roberta Lupoli, Giuseppe Della Pepa, Lutgarda Bozzetto, Luisa Palmisano, Angela Albarosa Rivellese, Gabriele Riccardi, Brunella Capaldo

Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study

Jia Peng, Ming-Ming Liu, Jing-Lu Jin, Ye-Xuan Cao, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jing Sun, Rui-Xia Xu, Jian-Jun Li

Adolescent BMI and early-onset type 2 diabetes among Ethiopian immigrants and their descendants: a nationwide study

Maya Simchoni, Uri Hamiel, Orit Pinhas-Hamiel, Inbar Zucker, Tali Cukierman-Yaffe, Miri Lutski, Estela Derazne, Zivan Beer, Doron Behar, Lital Keinan-Boker, Ofri Mosenzon, Dorit Tzur, Arnon Afek, Amir Tirosh, Itamar Raz, Gilad Twig

Impact of combined training with different exercise intensities on inflammatory and lipid markers in type 2 diabetes: a secondary analysis from a 1-year randomized controlled trial

João P. Magalhães, Diana A. Santos, Inês R. Correia, Megan Hetherington-Rauth, Rogério Ribeiro, João F. Raposo, Andreia Matos, Manuel D. Bicho, Luís B. Sardinha

Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study

  • Open Access
  • Diabetes
  • Original investigation

Federico Biscetti, Elisabetta Nardella, Maria Margherita Rando, Andrea Leonardo Cecchini, Flavia Angelini, Alessandro Cina, Roberto Iezzi, Marco Filipponi, Angelo Santoliquido, Dario Pitocco, Raffaele Landolfi, Andrea Flex

High glycated albumin is an independent predictor of low response to clopidogrel in ACS patients: a cross-sectional study

Xiliang Zhao, Quan Li, Chenchen Tu, Yong Zeng, Yicong Ye

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis

Kai-Cheng Chang, Shih-Chieh Shao, Shihchen Kuo, Chen-Yi Yang, Hui-Yu Chen, Yuk-Ying Chan, Huang-Tz Ou

Use of the ankle-brachial index combined with the percentage of mean arterial pressure at the ankle to improve prediction of all-cause mortality in type 2 diabetes mellitus: an observational study

Yu-Hsuan Li, Wayne Huey-Herng Sheu, I-Te Lee

Cardiovascular risks and bleeding with non-vitamin K antagonist oral anticoagulant versus warfarin in patients with type 2 diabetes: a tapered matching cohort study

Dahai Yu, Zhanzheng Zhao, David Simmons

Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial

Magnus O. Wijkman, Brian Claggett, Rafael Diaz, Hertzel C. Gerstein, Lars Køber, Eldrin Lewis, Aldo P. Maggioni, Emil Wolsk, David Aguilar, Rhonda Bentley-Lewis, John J. McMurray, Jeffrey Probstfield, Matthew Riddle, Jean-Claude Tardif, Scott D. Solomon, Marc A. Pfeffer

Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial

Antonio Ceriello, Anne Pernille Ofstad, Isabella Zwiener, Stefan Kaspers, Jyothis George, Antonio Nicolucci

Incidence of idiopathic cardiomyopathy in patients with type 2 diabetes in Taiwan: age, sex, and urbanization status-stratified analysis

Hua-Fen Chen, Ya-Hui Chang, Hsien-Jung Lo, Muhammad Atoillah Isfandiari, Santi Martini, Wen-Hsuan Hou, Chung-Yi Li

Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study

  • Open Access
  • Insulins
  • Original investigation

Chaterina Sujana, Jochen Seissler, Jens Jordan, Wolfgang Rathmann, Wolfgang Koenig, Michael Roden, Ulrich Mansmann, Christian Herder, Annette Peters, Barbara Thorand, Cornelia Then

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

Chao Gao, Mariusz Tomaniak, Kuniaki Takahashi, Hideyuki Kawashima, Rutao Wang, Hironori Hara, Masafumi Ono, Gilles Montalescot, Scot Garg, Michael Haude, Ton Slagboom, Pascal Vranckx, Marco Valgimigli, Stephan Windecker, Robert-Jan van Geuns, Christian Hamm, Philippe Gabriel Steg, Yoshinobu Onuma, Dominick J. Angiolillo, Patrick W. Serruys

MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction

Jesper Jensen, Morten Schou, Caroline Kistorp, Jens Faber, Tine W. Hansen, Magnus T. Jensen, Henrik U. Andersen, Peter Rossing, Tina Vilsbøll, Peter G. Jørgensen

Blood pressure levels and cardiovascular risk according to age in patients with diabetes mellitus: a nationwide population-based cohort study

Hack-Lyoung Kim, Hyue Mee Kim, Chang Hee Kwon, Jeong-Hun Shin, Mi-Hyang Jung, Chan Joo Lee, Dae-Hee Kim, Woo-Hyeun Kim, Si-Hyuck Kang, Ju-Hee Lee, In Jeong Cho, Iksung Cho, Jun Hyeok Lee, Dae Ryong Kang, Hae-Young Lee, Wook-Jin Chung, Sang-Hyun Ihm, Kwang Il Kim, Eun Joo Cho, Il-Suk Sohn, Hyeon-Chang Kim, Jinho Shin, Ju Han Kim, Sung Kee Ryu, Seok-Min Kang, Wook Bum Pyun, Myeong-Chan Cho, Sungha Park, Ki-Chul Sung

Global trend of diabetes mortality attributed to vascular complications, 2000–2016

Wei Ling, Yi Huang, Yan-Mei Huang, Rong-Rong Fan, Yi Sui, Hai-Lu Zhao

Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus

Claudia Lucci, Nicola Cosentino, Stefano Genovese, Jeness Campodonico, Valentina Milazzo, Monica De Metrio, Maurizio Rondinelli, Daniela Riggio, Maria Luisa Biondi, Mara Rubino, Katia Celentano, Alice Bonomi, Nicolò Capra, Fabrizio Veglia, Piergiuseppe Agostoni, Antonio L. Bartorelli, Giancarlo Marenzi

Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes

Annemie Stege Bojer, Martin Heyn Sørensen, Niels Vejlstrup, Jens P. Goetze, Peter Gæde, Per Lav Madsen

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

Guntram Schernthaner, Naim Shehadeh, Alexander S. Ametov, Anna V. Bazarova, Fahim Ebrahimi, Peter Fasching, Andrej Janež, Péter Kempler, Ilze Konrāde, Nebojša M. Lalić, Boris Mankovsky, Emil Martinka, Dario Rahelić, Cristian Serafinceanu, Jan Škrha, Tsvetalina Tankova, Žydrūnė Visockienė

Serum alkaline phosphatase levels and the risk of new-onset diabetes in hypertensive adults

  • Open Access
  • Original investigation

Yuanyuan Zhang, Chun Zhou, Jianping Li, Yan Zhang, Di Xie, Min Liang, Binyan Wang, Yun Song, Xiaobin Wang, Yong Huo, Fan Fan Hou, Xiping Xu, Xianhui Qin

Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance

C. Macchi, C. Favero, A. Ceresa, L. Vigna, D. M. Conti, A. C. Pesatori, G. Racagni, A. Corsini, N. Ferri, C. R. Sirtori, M. Buoli, V. Bollati, M. Ruscica

The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors

Ann Wan-Chin Ling, Cze-Ci Chan, Shao-Wei Chen, Yi-Wei Kao, Chien-Ying Huang, Yi-Hsin Chan, Pao-Hsien Chu

Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study

Tien-Hsing Chen, Yan-Rong Li, Shao-Wei Chen, Yu-Sheng Lin, Chi-Chin Sun, Dong-Yi Chen, Chun-Tai Mao, Michael Wu, Chih-Hsiang Chang, Pao-Hsien Chu, Victor Chien-Chia Wu

Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics

  • Open Access
  • Statins
  • Original investigation

Mario Luca Morieri, Angelo Avogaro, Gian Paolo Fadini

Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study

  • Open Access
  • Obesity
  • Original investigation

Se-Jun Park, Kyoung Hwa Ha, Dae Jung Kim

Prognostic irrelevance of plaque vulnerability following plaque sealing in high-risk patients with type 2 diabetes: an optical coherence tomography study

Rosalia Dettori, Andrea Milzi, Kathrin Burgmaier, Mohammad Almalla, Martin Hellmich, Nikolaus Marx, Sebastian Reith, Mathias Burgmaier

Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report

Etheresia Pretorius, Chantelle Venter, Gert Jacobus Laubscher, Petrus Johannes Lourens, Janami Steenkamp, Douglas B. Kell

Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes

Bin Feng, Guidong Xu, Kangyun Sun, Kaipeng Duan, Bimin Shi, Nannan Zhang

Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort

María J. Guembe, Cesar I. Fernandez-Lazaro, Carmen Sayon-Orea, Estefanía Toledo, Conchi Moreno-Iribas, Joaquín Barba Cosials, Jesús Berjón Reyero, Javier Díez Martínez, Paulino González Diego, Ana Ma Grijalba Uche, David Guerrero Setas, Eduardo Martínez Vila, Manuel Serrano Martínez, Isabel Sobejano Tornos, José Javier Viñes Rueda

Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk

Francesco Giorgino, Jiten Vora, Peter Fenici, Anna Solini

Association between adipocyte fatty acid-binding protein with left ventricular remodelling and diastolic function in type 2 diabetes: a prospective echocardiography study

Mei-Zhen Wu, Chi-Ho Lee, Yan Chen, Shuk-Yin Yu, Yu-Juan Yu, Qing-Wen Ren, Ho-Yi Carol Fong, Pui-Fai Wong, Hung-Fat Tse, Siu-Ling Karen Lam, Kai-Hang Yiu

Effects of metformin on atrial and ventricular arrhythmias: evidence from cell to patient

Teerapat Nantsupawat, Wanwarang Wongcharoen, Siriporn C. Chattipakorn, Nipon Chattipakorn

Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis

Gilles R. Dagenais, Lars Rydén, Lawrence A. Leiter, Mark Lakshmanan, Leanne Dyal, Jeffrey L. Probstfield, Charles Messan Atisso, Jonathan E. Shaw, Ignacio Conget, William C. Cushman, Patricio Lopez-Jaramillo, Fernando Lanas, Ernesto German Cordona Munoz, Valdis Pirags, Nana Pogosova, Jan Basile, Wayne H. H. Sheu, Theodora Temelkova-Kurktschiev, Peter J. Raubenheimer, Matyas Keltai, Stephanie Hall, Prem Pais, Helen M. Colhoun, Matthew C. Riddle, Hertzel C. Gerstein

Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial

João Pedro Ferreira, Subodh Verma, David Fitchett, Anne Pernille Ofstad, Sabine Lauer, Isabella Zwiener, Jyothis George, Christoph Wanner, Bernard Zinman, Silvio E. Inzucchi

Marked effects of novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate in severe hypertriglyceridemia: preliminary report

  • Open Access
  • Fibrates
  • Original investigation

Chie Iitake, Daisaku Masuda, Masahiro Koseki, Shizuya Yamashita

Cardiac resynchronization therapy and its effects in patients with type 2 DIAbetes mellitus OPTimized in automatic vs. echo guided approach. Data from the DIA-OPTA investigators

Celestino Sardu, Pasquale Paolisso, Valentino Ducceschi, Matteo Santamaria, Cosimo Sacra, Massimo Massetti, Antonio Ruocco, Raffaele Marfella

Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation

  • Open Access
  • Diabetes
  • Original investigation

Takayuki Ishihara, Yohei Sotomi, Takuya Tsujimura, Osamu Iida, Tomoaki Kobayashi, Yuma Hamanaka, Takashi Omatsu, Yasushi Sakata, Yoshiharu Higuchi, Toshiaki Mano

Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke

Karl Matz, Jaakko Tuomilehto, Yvonne Teuschl, Alexandra Dachenhausen, Michael Brainin

Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study

Abdullah M. Alguwaihes, Mohammed E. Al-Sofiani, Maram Megdad, Sakhar S. Albader, Mohammad H. Alsari, Ali Alelayan, Saad H. Alzahrani, Shaun Sabico, Nasser M. Al-Daghri, Anwar A. Jammah

How should we monitor the cardiovascular benefit of sodium–glucose cotransporter 2 inhibition?

Atsushi Tanaka, Koichi Node

Insulin directly stimulates mitochondrial glucose oxidation in the heart

  • Open Access
  • Insulins
  • Original investigation

Qutuba G. Karwi, Cory S. Wagg, Tariq R. Altamimi, Golam M. Uddin, Kim L. Ho, Ahmed M. Darwesh, John M. Seubert, Gary D. Lopaschuk

Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes

Shaminie J. Athinarayanan, Sarah J. Hallberg, Amy L. McKenzie, Katharina Lechner, Sarah King, James P. McCarter, Jeff S. Volek, Stephen D. Phinney, Ronald M. Krauss

Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study

  • Open Access
  • Insulins
  • Original investigation

Jie Shi, Weiwei Zhang, Yixin Niu, Ning Lin, Xiaoyong Li, Hongmei Zhang, Renming Hu, Guang Ning, Jiangao Fan, Li Qin, Qing Su, Zhen Yang

The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data

  • Open Access
  • Insulins
  • Original investigation

Byoungjin Park, Yong-Jae Lee, Hye Sun Lee, Dong-Hyuk Jung

Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease

Yun Shen, Dongjun Dai, Jingyi Lu, Yufei Wang, Wei Zhu, Yuqian Bao, Gang Hu, Jian Zhou

Heart failure documentation in outpatients with diabetes and volume overload: an observational cohort study from the Diabetes Collaborative Registry

  • Open Access
  • Diuretics
  • Original investigation

Suzanne V. Arnold, Philip G. Jones, Michael Beasley, Jeanine Cordova, Abhinav Goyal, Gregg C. Fonarow, Leo Seman

Correction to: Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt-sensitive rats fed a high-salt and high-fat diet

  • Open Access
  • Correction

Masatoki Yoshida, Kazufumi Nakamura, Toru Miyoshi, Masashi Yoshida, Megumi Kondo, Kaoru Akazawa, Tomonari Kimura, Hiroaki Ohtsuka, Yuko Ohno, Daiji Miura, Hiroshi Ito

Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events

Pratibha Singh, Isabel Goncalves, Christoffer Tengryd, Mihaela Nitulescu, Ana F. Persson, Fong To, Eva Bengtsson, Petr Volkov, Marju Orho-Melander, Jan Nilsson, Andreas Edsfeldt

Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

Giuseppe De Luca, Miha Cercek, Lisette Okkels Jensen, Marija Vavlukis, Lucian Calmac, Tom Johnson, Gerard Roura i Ferrer, Vladimir Ganyukov, Wojtek Wojakowski, Clemens von Birgelen, Francesco Versaci, Jurrien Ten Berg, Mika Laine, Maurits Dirksen, Gianni Casella, Petr Kala, José Luis Díez Gil, Victor Becerra, Ciro De Simone, Xavier Carrill, Alessandra Scoccia, Arpad Lux, Tomas Kovarnik, Periklis Davlouros, Gabriele Gabrielli, Xacobe Flores Rios, Nikola Bakraceski, Sébastien Levesque, Vincenzo Guiducci, Michał Kidawa, Lucia Marinucci, Filippo Zilio, Gennaro Galasso, Enrico Fabris, Maurizio Menichelli, Stephane Manzo, Gianluca Caiazzo, Jose Moreu, Juan Sanchis Forés, Luca Donazzan, Luigi Vignali, Rui Teles, Francisco Bosa Ojeda, Heidi Lehtola, Santiago Camacho-Freiere, Adriaan Kraaijeveld, Ylitalo Antti, Marco Boccalatte, Iñigo Lozano Martínez-Luengas, Bruno Scheller, Dimitrios Alexopoulos, Giuseppe Uccello, Benjamin Faurie, Alejandro Gutierrez Barrios, Bor Wilbert, Giuliana Cortese, Raul Moreno, Guido Parodi, Elvin Kedhi, Monica Verdoia

Dec 19
Issue: 1/2019
Dec 21
Issue: 1/2021

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar
Image Credits